[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Starling Oncology Institute Inc (STLN)

Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 622,686
  • Shares Outstanding, K 98,839
  • Annual Sales, $ 502,730 K
  • Annual Income, $ -60,610 K
  • EBIT $ -19 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.38
  • Price/Sales 1.21
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 114.25% (+36.43%)
  • Historical Volatility 89.62%
  • IV Percentile 82%
  • IV Rank 54.74%
  • IV High 154.16% on 08/04/26
  • IV Low 65.98% on 08/10/26
  • Expected Move (DTE 23) 0.30 (4.71%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 3,061
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 60,766
  • Open Int (30-Day) 60,343
  • Expected Range 6.02 to 6.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 1
  • High Estimate $-0.07
  • Low Estimate $-0.07
  • Prior Year $-0.14
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.70 +34.36%
on 07/28/26
7.05 -10.43%
on 08/07/26
+1.34 (+26.81%)
since 07/24/26
3-Month
4.22 +49.64%
on 06/03/26
7.05 -10.43%
on 08/07/26
+1.72 (+37.58%)
since 05/26/26
52-Week
2.32 +172.20%
on 02/13/26
7.05 -10.43%
on 08/07/26
+2.83 (+80.95%)
since 08/26/25

Most Recent Stories

More News
Starling Oncology to Participate in Wells Fargo Healthcare Conference

CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United...

STLN : 6.41 (+1.75%)
TOIIW : 0.0490 (-2.00%)
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United...

STLN : 6.41 (+1.75%)
TOIIW : 0.0490 (-2.00%)
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States,...

STLN : 6.41 (+1.75%)
TOIIW : 0.0490 (-2.00%)

Business Summary

Starling Oncology Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Starling Oncology Inc., formerly known as The Oncology Institute Inc., is based in CERRITOS, Calif.

See More

Key Turning Points

3rd Resistance Point 6.59
2nd Resistance Point 6.46
1st Resistance Point 6.38
Last Price 6.41
1st Support Level 6.17
2nd Support Level 6.03
3rd Support Level 5.95

See More

52-Week High 7.05
Last Price 6.41
Fibonacci 61.8% 5.24
Fibonacci 50% 4.68
Fibonacci 38.2% 4.13
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.